Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Thyroid : Official Journal of the American Thyroid Association|September 13, 2002
Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinomaAnne Bachelot, Anne Françoise Cailleux, Michele Klain, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
131I effective half-life and dosimetry in thyroid cancer patientsHervé Remy, Isabelle Borget, Sophie Leboulleux, et al.Thyroid : Official Journal of the American Thyroid Association|December 6, 2011
Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospitalHervé Rémy, Jérémy Coulot, Isabelle Borget, et al.The Journal of Clinical Investigation|June 9, 2007
Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switchClaire Magnon, Paule Opolon, Marcel Ricard, et al.Clinical Endocrinology|March 3, 2009
Health outcomes of children fathered by patients treated with radioiodine for thyroid cancerJérôme-Philippe Garsi, Martin Schlumberger, Marcel Ricard, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnanciesJérôme-Philippe Garsi, Martin Schlumberger, Carole Rubino, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2016
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancerMarie Terroir, Isabelle Borget, François Bidault, et al.International Journal of Radiation Oncology, Biology, Physics|July 2, 2005
Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinomaCarole Rubino, Elisabeth Adjadj, Françoise Doyon, et al.Thyroid : Official Journal of the American Thyroid Association|March 19, 2019
Redifferentiation of a BRAF-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib TreatmentSophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.The New England Journal of Medicine|May 4, 2012
Strategies of radioiodine ablation in patients with low-risk thyroid cancerMartin Schlumberger, Bogdan Catargi, Isabelle Borget, et al.Pageof 3